These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18422380)

  • 1. Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK.
    Becker C; Jick SS; Meier CR
    Drug Saf; 2008; 31(5):399-407. PubMed ID: 18422380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and the risk of dementia.
    Jick H; Zornberg GL; Jick SS; Seshadri S; Drachman DA
    Lancet; 2000 Nov; 356(9242):1627-31. PubMed ID: 11089820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAID use and risk of Parkinson disease: a population-based case-control study.
    Becker C; Jick SS; Meier CR
    Eur J Neurol; 2011 Nov; 18(11):1336-42. PubMed ID: 21457177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis.
    Jick SS; Choi H; Li L; McInnes IB; Sattar N
    Ann Rheum Dis; 2009 Apr; 68(4):546-51. PubMed ID: 18662929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use and risk of first-time psoriasis diagnosis.
    Brauchli YB; Jick SS; Meier CR
    J Am Acad Dermatol; 2011 Jul; 65(1):77-83. PubMed ID: 21529997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and the risk of pneumonia: a population-based, nested case-control study.
    Schlienger RG; Fedson DS; Jick SS; Jick H; Meier CR
    Pharmacotherapy; 2007 Mar; 27(3):325-32. PubMed ID: 17316144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors and the risk of fractures.
    Meier CR; Schlienger RG; Kraenzlin ME; Schlegel B; Jick H
    JAMA; 2000 Jun; 283(24):3205-10. PubMed ID: 10866867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin use and risk of gallstone disease followed by cholecystectomy.
    Bodmer M; Brauchli YB; Krähenbühl S; Jick SS; Meier CR
    JAMA; 2009 Nov; 302(18):2001-7. PubMed ID: 19903921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and Parkinson's disease in Denmark.
    Ritz B; Manthripragada AD; Qian L; Schernhammer E; Wermuth L; Olsen J; Friis S
    Mov Disord; 2010 Jul; 25(9):1210-6. PubMed ID: 20629142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database.
    Liu G; Sterling NW; Kong L; Lewis MM; Mailman RB; Chen H; Leslie D; Huang X
    Mov Disord; 2017 Jun; 32(6):913-917. PubMed ID: 28370314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases.
    Corrao G; Zambon A; Bertù L; Botteri E; Leoni O; Contiero P
    J Epidemiol Community Health; 2004 Dec; 58(12):1047-51. PubMed ID: 15547071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cataract in patients treated with statins.
    Schlienger RG; Haefeli WE; Jick H; Meier CR
    Arch Intern Med; 2001 Sep; 161(16):2021-6. PubMed ID: 11525705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and newly diagnosed diabetes.
    Jick SS; Bradbury BD
    Br J Clin Pharmacol; 2004 Sep; 58(3):303-9. PubMed ID: 15327590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of pneumonia in patients taking statins: population-based nested case-control study.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    Br J Gen Pract; 2011 Nov; 61(592):e742-8. PubMed ID: 22054338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
    Visnegarwala F; Maldonado M; Sajja P; Minihan JL; Rodriguez-Barradas MC; Ong O; Lahart CJ; Hasan MQ; Balasubramanyam A; White AC
    J Infect; 2004 Nov; 49(4):283-90. PubMed ID: 15474625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.
    Vinogradova Y; Hippisley-Cox J; Coupland C; Logan RF
    Gastroenterology; 2007 Aug; 133(2):393-402. PubMed ID: 17681160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates.
    Dominiczak M
    Curr Opin Lipidol; 2009 Feb; 20(1):79-81. PubMed ID: 19106712
    [No Abstract]   [Full Text] [Related]  

  • 18. A case control study of age related macular degeneration and use of statins.
    Smeeth L; Cook C; Chakravarthy U; Hubbard R; Fletcher AE
    Br J Ophthalmol; 2005 Sep; 89(9):1171-5. PubMed ID: 16113375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease.
    Mutez E; Duhamel A; Defebvre L; Bordet R; Destée A; Kreisler A
    Pharmacol Res; 2009 Jul; 60(1):41-5. PubMed ID: 19427584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
    Dormuth CR; Hemmelgarn BR; Paterson JM; James MT; Teare GF; Raymond CB; Lafrance JP; Levy A; Garg AX; Ernst P;
    BMJ; 2013 Mar; 346():f880. PubMed ID: 23511950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.